Amarin Stock Is Sinking After a Bearish Assessment of Its Heart Drug

Oppenheimer analyst Leland Gershell argues that the stock, which closed Tuesday at $22.73, will fall to $7 within 18 months.

https://finance.yahoo.com/m/87aa1bbb...html?.tsrc=rss